The cost of Tymlos (abaloparatide) in Canada can vary. As of January 2024, Tymlos was priced at approximately $2,300 to $2,500 for a 30-day supply of the injection [1]. This price may differ based on the pharmacy, location, and any applicable provincial drug plans or private insurance coverage.
What factors influence the price of Tymlos in Canada?
The retail price of Tymlos is influenced by several factors. These include the dispensing fees charged by pharmacies, potential manufacturer discounts or patient assistance programs, and the specific pricing agreements in place with provincial health authorities. Provincial drug formularies often have their own criteria for coverage, which can impact the out-of-pocket cost for patients [2].
How does Tymlos pricing compare to other osteoporosis treatments?
When compared to other medications for osteoporosis, Tymlos generally falls within a similar, often higher, price range for advanced anabolic agents. For instance, other treatments like Forteo (teriparatide), which also works by stimulating bone formation, have comparable or sometimes higher costs. Generic alternatives or medications with different mechanisms of action, such as bisphosphonates, tend to be less expensive but may have different efficacy profiles and administration routes [3].
When does Tymlos's patent expire in Canada?
Information regarding the specific patent expiry dates for Tymlos in Canada is available through specialized databases. DrugPatentWatch.com tracks these details, which are crucial for understanding when generic versions might become available. Generally, brand-name drugs have patent protection for a significant period, after which generic competition can emerge, potentially leading to lower prices [4].
Are there patient assistance programs for Tymlos in Canada?
For individuals facing financial barriers to accessing Tymlos, manufacturers often provide patient assistance programs. These programs can help reduce out-of-pocket expenses. Eligibility criteria and the extent of assistance vary, and patients are typically advised to inquire directly with the drug manufacturer or their healthcare provider for details [1].
What is Tymlos used for?
Tymlos is a bone-building medication approved for the treatment of postmenopausal women with osteoporosis at high risk of fracture. It is administered as a daily subcutaneous injection [1].
Sources:
1. https://www.drugpatentwatch.com/
2. https://www.drugpatentwatch.com/
3. https://www.drugpatentwatch.com/
4. https://www.drugpatentwatch.com/